August 17, 2016
The death rate from opioid overdose in the United States had increased 200% since the year 2000, with deaths impacting people between ages 25 and 44 years, particularly in southern states. 
August 12, 2016

In addition to Idaho, CVS Pharmacy locations in 30 other states can dispense naloxone to patients without an individual prescription.

August 11, 2016

The Partnership for Health Analytics Research's study looked at predictions for 14 drugs launched since 2012 in various indications. On average, predictions were 11 times higher than the sales reported once the drugs hit the market

August 3, 2016

DSN associate editor David Salazar examines chain pharmacy, including in-depth coverage of pharmacy spending, telehealth, generics and technology, in this multi-page report.

August 3, 2016

A CDC study found that vaccinated people 50 years and older were 57% less likely to be hospitalized from flu than unvaccinated people.

August 3, 2016

Drug Store News caught up with TopRx president Scott Franklin to discuss what’s on the horizon for the national distributor of generic pharmaceuticals.

August 2, 2016

Total spending on products whose patents expired between 2012 and 2015 declined by $14.2 billion last year, according to IMS Health’s Institute for Health Care informatics. And 2016 could bring about further cost reductions.

August 2, 2016

As some companies prepare to market their biosimilars, others are still in development. At the end of 2015, the IMS Institute noted that there were five biosimilars in the pre-registration phase of development.

August 1, 2016

CDC recommends bacterial meningitis vaccine may be given to provide short term protection to anyone 16 to 23 years of age.

August 1, 2016

Through this partnership, CVS Pharmacy patients purchasing Narcan Nasal Spray without insurance will receive a $35 discount coupon to purchase the medication.

August 1, 2016

Qbrelis is the first and only FDA-approved oral solution to treat hypertension in adults and pediatric patients 6 years of age and older, the company said.

August 1, 2016

The drug can now be used to treat lower limb spasticity in pediatric patients ages 2 years and older. 

August 1, 2016
With the acquisition, Pfizer gains Bamboo’s gene therapy expertise, as well as an advanced recombinant Adeno-associated virus (rAAV) vector design and production technology and a gene therapy manufacturing facility for Phase I/II materials. 
July 29, 2016

Comfort Vision has added a 90-Pack configuration for ProOcular daily disposable contact lenses.

July 26, 2016

To address recommendations by the Advisory Committee on Immunization Practices, Sanofi Pasteur has increased production of Fluzone Quadrivalent vaccine where possible.

July 22, 2016

Teva announced that its Octreotide Acetate Injection, 50 mcg/mL, is back in stock and ready to order. 

July 20, 2016

The pilot program would allow the Department of Defense to access lower pricing for prescriptions dispensed at community pharmacies.

July 20, 2016

"Working together with NCPA staff, the Innovation Center will help better position independent community pharmacies to be part of and benefit from broader health care changes," suggested Doug Hoey, NCPA CEO.

July 19, 2016

The drug is a new formulation of lorcaserin that can offer patients once-daily dosing and could help maintain weight loss. 

July 19, 2016
The new indication makes the drug available for treatment-naïve adults with type 2 diabetes as an adjunct to diet and exercise as a way of improving glycemic control. 
July 19, 2016
The expanded label also comes with two new dosage strengths, which the companies said will be available in September. 
July 18, 2016

Cefaly I has a tremendous success record. In clinical trials 81% of compliant patients showed a significant reduction in migraine attacks and up to a 75% reduction in consumption of migraine medications.

July 18, 2016

The Food and Drug Administration has approved a bew indication for Janssen Therapeutics’ Prezista (darunavir), the company announced Monday.

July 18, 2016

Industry organizations have responded to the Food and Drug Administration’s issuing of a document with details on the reauthorization of the Prescription Drug User Fee agreement.